Immuneering CorporationIMRXNASDAQ
Loading
Enterprise value to EBITDA ratio
Latest
-2.81
↑ 67% vs avg
Percentile
P50
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-8.58
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -2.81 | -426.4% |
| 2024 | -0.53 | +79.9% |
| 2023 | -2.65 | -126.7% |
| 2022 | -1.17 | +88.9% |
| 2021 | -10.56 | +10.8% |
| 2020 | -11.83 | +61.2% |
| 2019 | -30.50 | - |